Masahiro Hoshino Selected Research

Masahiro Hoshino Research Topics

19	Cardiovascular Diseases (Cardiovascular Disease) 12/2023 - 12/2016
16	Myocardial Infarction 12/2023 - 04/2015
7	Heart Failure 12/2023 - 11/2018
7	Thrombosis (Thrombus) 06/2022 - 11/2017
7	Acute Coronary Syndrome 01/2022 - 03/2017
6	Rupture 10/2023 - 12/2017
6	Pathologic Constriction (Stenosis) 09/2022 - 01/2020
5	Coronary Artery Disease (Coronary Atherosclerosis) 12/2023 - 01/2019
5	Ischemia 01/2022 - 01/2018
4	Death (Near-Death Experience) 12/2023 - 01/2020
4	Inflammation (Inflammations) 01/2023 - 01/2020
4	Atherosclerotic Plaque (Atheroma) 01/2022 - 07/2019
4	AIDS-Related Complex (ARC) 01/2021 - 01/2018
3	Stroke (Strokes) 12/2023 - 12/2021
3	Renal Insufficiency (Renal Failure) 01/2022 - 03/2021
3	Diabetes Mellitus 01/2022 - 01/2020
2	MINOCA 09/2022 - 02/2021
2	Hyperemia 01/2022 - 01/2021
2	Infarction (Infarctions) 01/2022 - 10/2021
2	Neointima 03/2021 - 07/2019
2	Stable Angina 01/2020 - 04/2019
2	Necrosis 01/2018 - 01/2017
1	Infections 08/2022
1	Postoperative Pain 08/2022
1	Pain (Aches) 02/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Hemorrhage 01/2021
1	Coronary Disease (Coronary Heart Disease) 01/2021
1	ST Elevation Myocardial Infarction 07/2020
1	Coronary Thrombosis 01/2019
1	Spasm (Spasms) 12/2016
1	Chest Pain (Chest Pains) 04/2015

20	omega-Chloroacetophenone (Mace)IBA 12/2023 - 12/2016
8	LipidsIBA 06/2022 - 01/2018
3	CholesterolIBA 10/2023 - 01/2021
3	CalciumIBA 01/2023 - 01/2021
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 01/2018
3	pro-brain natriuretic peptide (1-76)IBA 12/2021 - 03/2019
3	Troponin IIBA 12/2021 - 04/2015
3	Brain Natriuretic Peptide (Natrecor)FDA Link 09/2021 - 03/2019
3	C-Reactive ProteinIBA 09/2021 - 01/2020
2	Dextrans (Dextran)FDA Link 09/2021 - 03/2021
2	oxidized low density lipoproteinIBA 01/2020 - 07/2019
2	LDL CholesterolIBA 01/2020 - 07/2019
1	GadoliniumIBA 01/2023
1	Glucose (Dextrose)FDA LinkGeneric 01/2023
1	SymportersIBA 01/2023
1	SodiumIBA 01/2023
1	empagliflozinIBA 01/2023
1	pleiotrophin (HARP)IBA 09/2022
1	MM 36IBA 02/2022
1	Sirolimus (Rapamycin)FDA Link 01/2022
1	Vasodilator Agents (Vasodilators)IBA 01/2022
1	Contrast MediaIBA 09/2021
1	Hemoglobins (Hemoglobin)IBA 09/2021
1	CreatinineIBA 03/2021
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 02/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Dichlorodiphenyldichloroethane (DDD)IBA 01/2021
1	TroponinIBA 06/2019
1	Factor Xa InhibitorsIBA 11/2017
1	AnticoagulantsIBA 11/2017
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 03/2017
1	Isosorbide Dinitrate (Isordil)FDA LinkGeneric 12/2016

21	Percutaneous Coronary Intervention 12/2023 - 01/2018
8	Stents 01/2022 - 12/2017
2	Patient Readmission 09/2023 - 01/2023
2	Therapeutics 01/2022 - 11/2017
1	Aftercare (After-Treatment) 01/2023
1	Operative Time 08/2022
1	Myocardial Revascularization 10/2021
1	Catheters 01/2017